Jeff Yass’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Jeff Yass’s Portfolio MRNY Stock Details MRNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$362K	Sell	18,737 -35,423	-65%	-$597K	﹤0.01%	10638
2026 Q1	$1.01M	Buy	+54,160	New	+$1.02M	﹤0.01%	7865
2025 Q4	–	Sell	-21,091	Closed	-$373K	–	13133
2025 Q3	$373K	Buy	+21,091	New	+$437K	﹤0.01%	9622
2025 Q2	–	Sell	-9,773	Closed	-$270K	–	13333
2025 Q1	$270K	Buy	9,773 +5,459	+127%	+$210K	﹤0.01%	10297
2024 Q4	$227K	Buy	4,314 +3,090	+252%	+$193K	﹤0.01%	10447
2024 Q3	$108K	Sell	1,224 -780	-39%	-$92.9K	﹤0.01%	11004
2024 Q2	$309K	Buy	+2,004	New	+$395K	﹤0.01%	9374

Other funds holding MRNY

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

WCM

Winebrenner Capital Management Louisville, Kentucky $164M AUM 12.81% 1-Year Est. Return

MCA

McGuire Capital Advisors Bethany, Oklahoma $183M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

KCM

Key Capital Management Hendersonville, Tn 37075, Tennessee $194M AUM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $4.96B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jeff Yass's MRNY Position: Q2 2026 in Review

Jeff Yass reduced its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 65% in Q2 2026, selling an estimated $597K and leaving 18,737 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #10638.

Jeff Yass first reported a position in MRNY in Q2 2024 and has held it in 7 quarters since. The position peaked at $1.01M in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

Jeff Yass held 18,737 shares of YieldMax MRNA Option Income Strategy ETF worth $362K as of Q2 2026.
Jeff Yass sold 35,423 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $597K.
YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10638 holding.
Jeff Yass first reported a position in YieldMax MRNA Option Income Strategy ETF in Q2 2024 and has held it in 7 quarters since.
Jeff Yass's YieldMax MRNA Option Income Strategy ETF position peaked at $1.01M in Q1 2026.
10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.